A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly

Immunogenicity and safety of a booster dose of an MF59-adjuvanted H5N1 vaccine containing 7.5 μg A/turkey/Turkey/1/2005-like (clade 2.2) H5N1 hemagglutinin, given approximately 18 months after primary vaccination with a heterologous strain, were evaluated. The booster vaccine was well tolerated and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Fragapane, Elena, Gasparini, Roberto, Schioppa, Francesco, Laghi-Pasini, Franco, Montomoli, Emanuele, Banzhoff, Angelika
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2010
Teme:
Vaccine Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2976095/
https://ncbi.nlm.nih.gov/pubmed/20810680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00461-09
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items